The condition of the cardiovascular system in patients with relapsing-remitting multiple sclerosis

The condition of the cardiovascular system in patients with relapsing-remitting multiple sclerosis

The aim of the reserch was to study the state of the cardiovascular system, systemic inflammation and balance oxidant/|antioxidant in patients with relapsing-remitting multiple sclerosis.Material and methods. The study included 45 patients with relapsing-remitting multiple sclerosis (17 men and 28 w...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. A. Traktirskaya, T. V. Adasheva, A. N. Boyko, E. V. Popova
Format:	Article
Language:	Russian
Published:	SINAPS LLC 2019-03-01
Series:	Архивъ внутренней медицины
Subjects:	multiple sclerosis cardiovascular diseases oxidative stress antioxidant protection endothelial dysfunction arterial stiffness
Online Access:	https://www.medarhive.ru/jour/article/view/904
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Assessing female sexual dysfunction in patients with relapsing-remitting multiple sclerosis
by: Elisa Matias Vieira de Melo, et al.
Published: (2025-04-01)

Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
by: V. M. Alifirova, et al.
Published: (2010-08-01)

Adherence to therapeutic recommendation in relapsing-remitting multiple sclerosis patients
by: Justyna Chojdak-Łukasiewicz, et al.
Published: (2025-06-01)

Cognitive profile of patients with relapsing remitting multiple sclerosis
by: VIVIAN M. ANDRADE, et al.
Published: (1999-09-01)

Volumetric assessment of hypothalamus in relapsing–remitting multiple sclerosis
by: Sara Sameh AbdelRahman Abdallah, et al.
Published: (2025-07-01)

Comparative Effects of Vitamin D Supplementation on Oxidative Stress in Relapsing–Remitting Multiple Sclerosis
by: Martyna Lis, et al.
Published: (2024-12-01)

Longitudinal analysis of verbal episodic memory in patients with relapsing-remitting multiple sclerosis
by: Izadora Nogueira Fonte Boa, et al.

Experience with the long-term use of interferons β in the treatment of relapsing-remitting multiple sclerosis. Case report
by: Taras O. Simaniv, et al.
Published: (2024-12-01)

Neurocardiology Update: The Brain–Heart Connection in Multiple Sclerosis—A Narrative Review
by: Nicoleta Gherghel‐Pavăl, et al.
Published: (2025-03-01)

Differentiation of relapsing-remitting and secondary progressive multiple sclerosis: a magnetic resonance spectroscopy study based on machine learning
by: Ziya EKŞİ, et al.

Corrigendum: Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis
by: Fernando Rodríguez-Jorge, et al.
Published: (2024-12-01)

A Prospective Study on 25 Hydroxyvitamin D Serum Levels in Patients with Relapsing-Remitting Multiple Sclerosis
by: Georgi Slavov, et al.
Published: (2014-11-01)

Cost-Consequences of Cladribine Tablets for the Treatment of Highly Active Relapsing–Remitting Multiple Sclerosis in Italy
by: Barbara Polistena, et al.
Published: (2025-06-01)

Influence of von Willebrand factor on common pathophysiological mechanisms of cerebrovascular diseases and multiple sclerosis
by: I. A. Koltsov, et al.
Published: (2021-09-01)

Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple Sclerosis
by: Alice G. Willison, et al.
Published: (2025-04-01)

Motor symptoms and the quality of life of relapsing-remitting multiple sclerosis patients in a specialized center in South of Brazil
by: Francielle Fontana Jorge, et al.
Published: (2021-01-01)

Role of Diet and Supplementation with Omega-3 Polyunsaturated Fatty Acids for Managing Chronic Fatigue in Patients with Relapsing-Remitting Multiple Sclerosis
by: Nicholas Shepherd, et al.
Published: (2022-11-01)

Mental health outcomes in pregnant women with relapsing-remitting multiple sclerosis: a longitudinal cohort study
by: Lena Kristina Pfeffer, et al.
Published: (2025-07-01)

Positive correlation between functional disability, excessive daytime sleepiness, and fatigue in relapsing-remitting multiple sclerosis
by: Douglas Martins Braga, et al.
Published: (2016-06-01)

AI-driven MRI analysis reveals brain atrophy patterns in benign relapsing-remitting multiple sclerosis
by: M. Niiranen, et al.
Published: (2025-05-01)

Dawson’s finger radiological presentation of relapsing remitting multiple sclerosis in a young female: a case report and review of the literature
by: Hadeel Al-Husban, et al.
Published: (2025-04-01)

Evaluation of the Efficacy, Safety, and Adherence to Oral Drug Therapy in Patients with Relapsing–Remitting Multiple Sclerosis
by: Paulius Sėdžius, et al.
Published: (2025-04-01)

Reabilitação vestibular em pacientes com esclerose múltipla remitente-recorrente Vestibular rehabilitation in patients with relapsing- remitting multiple sclerosis
by: Karina Pavan, et al.
Published: (2007-06-01)

Prospects of laboratory risk evaluation of multiple sclerosis relapse and progressing
by: I. V. Smagina, et al.
Published: (2010-08-01)

Threatening illness perception and associated factors in early-stage relapsing-remitting multiple sclerosis
by: Rocío Gómez-Ballesteros, et al.
Published: (2025-07-01)

Cognitive Deficits in Children with Multiple Sclerosis
by: J Gordon Millichap
Published: (2005-05-01)

Optimization of therapy in secondary progressive multiple sclerosis
by: A. N. Boyko, et al.
Published: (2024-08-01)

Characteristics and correlations of sleep disorders in patients with relapsing–remitting multiple sclerosis in China: a cross-sectional study
by: Rongrong Wang, et al.
Published: (2025-07-01)

Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis
by: A. N. Boyko, et al.
Published: (2019-11-01)

Predictive Significance of Interleukins 17A and 33 in Risk of Relapsing–Remitting Multiple Sclerosis
by: Milad Abdul Salam Al-Naseri, et al.
Published: (2022-12-01)

Assessment of the impact of reconstitution therapies—cladribine tablets and alemtuzumab—on the atrophy progression among patients with relapse-remitting multiple sclerosis
by: Aleksandra Pogoda-Wesołowska, et al.
Published: (2025-02-01)

First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis
by: Simona Toscano, et al.
Published: (2025-03-01)

The influence of personality traits and coping strategies on the quality of life of patients with relapsing-remitting type of multiple sclerosis
by: Krstić Dragan, et al.
Published: (2021-01-01)

Gadolinium deposition in the brain of patients with relapsing-remitting multiple sclerosis after 10 years of follow-up
by: Kostić Dejan, et al.
Published: (2023-01-01)

Cost-Minimization Analysis and Budget Impact Analysis About Subcutaneous Natalizumab in Relapsing-Remitting Multiple Sclerosis in Italy
by: Prosperini L, et al.
Published: (2025-04-01)

Fadiga na forma remitente recorrente da esclerose múltipla Fatigue in multiple sclerosis relapsing-remitting form
by: MARIA FERNANDA MENDES, et al.
Published: (2000-06-01)

Correction: Characteristics and correlations of sleep disorders in patients with relapsing–remitting multiple sclerosis in China: a cross-sectional study
by: Rongrong Wang, et al.
Published: (2025-08-01)

Associations among IL-6 Signaling Molecules in Treg Populations in Patients with Relapsing-Remitting Multiple Sclerosis
by: Magdalena Kierasińska, et al.
Published: (2025-05-01)

The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of ofatumumab
by: I. Jonušaitė, et al.
Published: (2024-03-01)

DISRUPTIONS OF ELASTIC ARTERIES PROPERTIES AND ENDOTHELIAL FUNCTION: MODERN METHODS FOR CORRECTION AND PREVENTION
by: A. F. Kolpakova
Published: (2015-06-01)